Drug profile · INN
nafcillin sodium
NAFCILLIN SODIUM
nafcillin sodium (NAFCILLIN SODIUM) is a penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — nafcillin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
nafcillin sodium (NAFCILLIN SODIUM) is a penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Penicillin-binding protein inhibitor
Primary target: Penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is nafcillin sodium?
nafcillin sodium (NAFCILLIN SODIUM) is a penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for nafcillin sodium?
NAFCILLIN SODIUM is a marketed brand name for nafcillin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nafcillin sodium?
nafcillin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.